0000947871-23-000336.txt : 20230317
0000947871-23-000336.hdr.sgml : 20230317
20230317162956
ACCESSION NUMBER: 0000947871-23-000336
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230227
FILED AS OF DATE: 20230317
DATE AS OF CHANGE: 20230317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GORDON CARL L
CENTRAL INDEX KEY: 0001282930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 23743027
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OrbiMed Israel GP Ltd.
CENTRAL INDEX KEY: 0001569590
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 23743028
BUSINESS ADDRESS:
STREET 1: 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR
CITY: HERZLIYA
STATE: L3
ZIP: 46766
BUSINESS PHONE: 212-739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022-4629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OrbiMed Israel BioFund GP Limited Partnership
CENTRAL INDEX KEY: 0001569821
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 23743029
BUSINESS ADDRESS:
STREET 1: 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR
CITY: HERZLIYA
STATE: L3
ZIP: 46766
BUSINESS PHONE: 212-739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 1022-4629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chimovits Erez
CENTRAL INDEX KEY: 0001706399
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 23743026
MAIL ADDRESS:
STREET 1: P.O. BOX 4023
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 4614001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BiomX Inc.
CENTRAL INDEX KEY: 0001739174
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 EINSTEIN ST., 4TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
BUSINESS PHONE: (972) 72 394 2377
MAIL ADDRESS:
STREET 1: 22 EINSTEIN ST., 4TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20180430
4
1
ownership.xml
X0306
4
2023-02-27
0
0001739174
BiomX Inc.
PHGE
0001569821
OrbiMed Israel BioFund GP Limited Partnership
5 HAHOSHLIM STREET, BUILDING B, 1ST FL.
HERZLIYA PITUACH
L3
46686
ISRAEL
0
0
1
0
0001569590
OrbiMed Israel GP Ltd.
5 HAHOSHLIM STREET, BUILDING B, 1ST FL.
HERZLIYA PITUACH
L3
46686
ISRAEL
0
0
1
0
0001282930
GORDON CARL L
C/O ORBIMED ISRAEL GP LTD.
5 HAHOSHLIM STREET, BUILDING B, 1ST FL.
HERZLIYA PITUACH
L3
46686
ISRAEL
0
0
1
0
0001706399
Chimovits Erez
C/O ORBIMED ISRAEL GP LTD.
5 HAHOSHLIM STREET, BUILDING B, 1ST FL.
HERZLIYA PITUACH
L3
46686
ISRAEL
0
0
1
0
Common Stock
2023-02-27
4
P
0
348000
0.245
A
3161489
I
See Footnotes
Warrants (Right to Buy)
0.244
2023-02-27
4
P
0
1789959
A
2023-02-27
2033-02-27
Common Stock
1789959
1789959
I
See Footnotes
These shares of the Issuer's common stock and warrants to purchase shares of the Issuer's common stock were purchased from the Issuer in a private placement. The warrants are exercisable for one share of the Issuer's common stock per warrant, subject to an issuance limitation that prohibits the holder from exercising the warrants to the extent that after giving effect to such issuance after exercise, the holder (together with the holder's affiliates and any other persons acting as a group together with the holder or any of the holder's affiliates, including the Reporting Persons) would beneficially own in excess of 9.99% of the shares of common stock outstanding immediately after giving effect to the issuance of the shares of common stock issuance upon exercise of the warrants.
These securities are held of record by OrbiMed Israel Partners Limited Partnership ("OIP"). OrbiMed Israel BioFund GP Limited Partnership ("OrbiMed BioFund") is the general partner of OIP and OrbiMed Israel GP Ltd. ("OrbiMed Israel") is the general partner of OrbiMed BioFund. By virtue of such relationships, OrbiMed Israel and OrbiMed BioFund may be deemed to have voting and investment power over the securities held by OIP and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Israel exercises investment and voting power through an investment committee comprised of Carl L. Gordon and Erez Chimovits.
Each of OrbiMed Israel, OrbiMed BioFund, Carl Gordon, and Erez Chimovits disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
OrbiMed Israel GP Ltd., By: /s/ Douglas Coon, Chief Compliance Officer
2023-03-17
OrbiMed Israel BioFund GP Limited Partnership, By: /s/ Douglas Coon, Chief Compliance Officer
2023-03-17
/s/ Carl L. Gordon
2023-03-17
/s/ Erez Chimovits
2023-03-17